The CD40-CD154 system in anti-infective host defense

Current Opinion in Immunology

Volumn 9, Issue 4, 1997, Pages 491-497

  Grewal, Iqbal S ^a   Borrow, Persephone ^b   Pamer, Eric G ^a   Oldstone, Michael B A ^b   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Virology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39;

ANIMAL MODEL; ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; INFECTION RESISTANCE; INFLAMMATION; NONHUMAN; REVIEW; T LYMPHOCYTE;

EID: 0030862077     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80100-8     Document Type: Article

References (51)

1. Clark LB, Foy TM, Noelle RJ. CD40 and its ligand. of special interest Adv Immunol. 63:1996;43-78 This paper, along with [2], is a comprehensive review that summarizes the in vitro and in vivo studies utilizing anti-CD154 antibodies that have led to our current understanding of the CD40-CD154 mediated pathway and its regulatory role in the immune response.
2. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol. 14:1996;591-617.
3. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles of CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell. 87:1996;319-329.
4. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378:1995;617-620.
5. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CA Jr, Flavell RA. Requirement for CD40 ligand in costimulation induction, T cell activation and experimental allergic encephalomyelitis. of outstanding interest Science. 273:1996;1864-1867 This study shows that CD154 is required for T cell priming and provides evidence for the regulation in vivo of the induction of co-stimulation by the CD40-CD154 system. Data show that T cells in CD154-deficient mice fail to upregulate co-stimulatory activity in draining lymph nodes upon antigen challenge. In addition, self antigen reactive TCR transgenic T cells fail to be activated and are unable to cause autoimmunity in these mice. See also [6].
6. of special interest Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. of outstanding interest Science. 273:1996;1862-1864 Similar to [5], this study also provides evidence that CD40-CD154 interactions are required for the induction of in vivo co-stimulatory activity.
7. of outstanding interest Grewal IS, Flavell RA. A central role of CD40 ligand in the regulation of CD4 T cell responses. of special interest Immunol Today. 17:1996;410-414 A two step model for T cell activation, regulated by CD154 at the level of antigen presentation, is presented in this study. Recent data from in vivo studies using CD154-deficient mice are reviewed. See also [11].
8. Cella M, Scheidegger D, Palmer-Lehman K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. of special interest J Exp Med. 184:1996;747-752 The role of the CD40-CD154 interaction in the activation of DCs to produce cytokines and upregulate co-stimulatory activity is described. It is shown that CD40 triggering of DCs is important for the production of IL-12 and for up-regulation of the co-stimulatory molecules CD80 and CD86. See also [18].
9. of outstanding interest Ranhei EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med. 177:1993;925-935.
10. Wu Y, Xu J, Shinde S, Grewal IS, Henderson T, Flavell RA, Liu Y. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr Biol. 5:1995;1303-1311.
11. Grewal IS, Flavell RA. CD40-CD40L interactions in T cell activation. of special interest Immunol Rev. 153:1996;85-106 This paper reviews the in vivo role of the CD40-CD154 interaction in the regulation of immune responses. Studies using CD154-deficient mice are reviewed here. Experiments discussed here show the requirement of CD40-CD154 in T cell activation. See also [7].
12. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell. 76:1994;275-285.
13. Jenkins MK. The ups and downs of T cell costimulation. Immunity. 1:1994;443-446.
14. Roy M, Aruffo A, Ledbetter J, Linsley P, Kehry M, Noelle R. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol. 25:1995;596-603.
15. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 180:1994;1263-1272.
16. Peguet-Navarro J, Dalbiez-Gauthier C, Rattis FM, Van Kooten C, Banchereau J, Schmitt D. Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol. 155:1995;4241-4247.
17. Buhlmann JE, Foy TM, Aruffo A, Crassi KM, Ledbetter JA, Green WR, Xu J, Schultz LD, Roopesian D, Flavell RA, et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity. 2:1995;645-653.
18. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-10. of outstanding interest J Exp Med. 184:1996;741-746 Similar to [8], this study shows that murine DCs require CD40 and MHC class II mediated signals in order to produce IL-12, and that IL-12 can be downregulated by IL-10.
19. of special interest Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodel Rev. 3:1992;101-122.
20. Stout R, Suttles J. The many roles of CD40:CD40L interactions in cell-mediated inflammatory responses. of outstanding interest Immunol Today. 17:1996;487-492 This article reviews the current data on the role of the CD40-CD154 interaction in macrophage activation. Several studies showing CD40-CD154 regulated production of cytokines and other mediators of inflammation are reviewed.
21. Stout R, Suttles J, Xu J, Grewal I, Flavell R. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol. 156:1996;8-11.
22. Tian L, Noelle RJ, Lawrence DA. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol. 25:1995;306-309.
23. Stout RD, Suttles J. T Cell Signaling of Macrophage Activation: Cell Contact-Dependent and Cytokine Signals. 1995;RG Lanndes, Springer-Verlag, Austin.
24. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
25. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L. Functional Interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med. 182:1995;1857-1864.
26. Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA. 92:1995;4342-4346.
27. Karmann K, Min W, Fanslow WC, Pober JS. Activation and homologous desensitization of human endothelial necrosis factor, and interleukin 1. of special interest J Exp Med. 184:1996;173-182 This study, along with [24,26], indicates the expression of CD40 in cells other than conventional APCs, such as endothelial cells. Furthermore, the activation of endothelia to upregulate adhesion molecules and cytokines under the control of the CD40-CD154 system is demonstrated.
28. Janeway CA Jr, Travers P. edn 3 Immunobiology: the immune system in health and disease. 1997;Current Biology Ltd, London.
29. Janeway CA Jr, Travers P. edn 3 Immunobiology: the immune system in health and disease. 1997;Garland Publishing Inc. New York.
30. Seiler KP, Weis JJ. Immunity to Lyme disease: protection, pathology and persistence. Curr Opin Immunol. 8:1996;503-509.
31. Fikrig E, Barthold SW, Chen M, Grewal IS, Craft J, Flavell RA. Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol. 157:1996;1-3.
32. Urgan JF, Madden KB, Svetic A, Cheever A, Trotta PP, Gause WC, Katona IM, Finkelman FD. The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev. 127:1992;205-220.
33. Lu P, Urban JF, Zhou XD, Chen SJ, Madden K, Moorman M, Nguyen H, Morris SC, Finkelman FD, Gause WC. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production. J Immunol. 156:1996;3327-3333.
34. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 365:1993;340-343.
35. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 13:1995;151-157.
36. Soong L, Xu J, Grewal IS, Kima P, Sun J, Longley BJ Jr, Ruddle NH, McMahan-Pratt D, Flavell RA. Disruption of CD40-CD40 ligand interactions results is an enhanced susceptibility to Leishmania amazonesis infection. of special interest Immunity. 4:1996;263-273 This paper, along with [37], describes a critical role for CD154 in the regulation of Leishmania infection in CD154-deficient mice. These mice were unable to mount an effective antiparasite response due to the lack of macrophage activation and the concomitant lack of IL-12 and NO production. Thus, a role for CD154 in the maintenance of the Th1 type immune response that is required for containing a Leishmania infection is predicted. See also [36].
37. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. of special interest Immunity. 4:1996;275-281 A role for the CD40-CD154 system in the development of the anti L. major response is revealed by using CD40-deficient mice. See also [35,37].
38. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. of special interest Immunity. 4:1996;283-289 Similar to [35], a role for CD40-mediated signaling in the activation of macrophages and in the development of a Th1 type immune response is demonstrated. See also [36].
39. Barral A, Petersen EA, Sacks DL, Neva FA. Late metastatic leishmaniasis in the mouse: a model for mucocutaneous disease. Am J Trop Med Hyg. 32:1983;277-285.
40. Chen W, Havell EA, Moldawer LL, McIntyre KW, Chizzonite RA, Harmsen AG. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J Exp Med. 176:1992;713-718.
41. Chen W, Havell EA, Harmsen AG. Importance of endogeneous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii. Infect Immun. 60:1992;1279-1284.
42. Wiley JA, Harmsen AG. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J Immunol. 155:1995;3525-3529.
43. Borrow P, Oldstone MBA. Lymphocytic choriomeningitis virus. Nathanson N. Viral Pathogenesis. 1997;593-672 Lippencott-Raven, Philadelphia.
44. Borrow P, Tishon A, Lee S, Xu J, Grewal IS, Oldstone MB, Flavell RA. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. of special interest J Exp Med. 183:1996;2129-2142 This study, along with [44,45], shows that CD40-CD154 interactions are critical for antiviral humoral responses. These interactions, however, are not required for the development of primary antiviral CTL responses. Furthermore, it was demonstrated that CD154 plays a critical role in the development of CTL memory responses.
45. + T cell functions. of special interest J Exp Med. 183:1996;2209-2218 See annotation [43].
46. Whitemire JK, Slifka MK, Grewal IS, Flavell RA, Ahmed R. Primary immune response to a viral infection in CD40 ligand-deficient mice. of special interest J Virol. 70:1996;8375-8381 See annotation [43].
47. Steinhoff U, Muller U, Schertler A, Hengartner H, Aguet M, Zinkernagel RM. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J Virol. 69:1995;2153-2158.
48. Yang Y, Su Q, Grewal IS, Schilz R, Flavell RA, Wilson JM. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol. 70:1996;6370-6377.
49. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med. 1:1995;890-893.
50. Ruby J, Bluethmann H, Aguet M, Ramshaw IA. CD40 ligand has potent antiviral activity. Nat Med. 1:1995;437-441.
51. Pamer EG. Immune response to Listeria monocytogenes. Kaufmann SHE. Host Response to Intracellular Infection. 1997;131-142 RG Landes, Austin.